Daniel H. Libraty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel H. Libraty has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Rosario Z. Capeding
Department of Medicine, Research Institute for Tropical Medicine, Metro Manila, Philippines
11 shared publicationsJob D. Brion
San Pablo City Health Department, San Pablo, Laguna, Philippines
10 shared publicationsAnaMae Obcena
Department of Medicine, Research Institute for Tropical Medicine, Manila, Philippines
7 shared publicationsFrancis A. Ennis
Center for Infectious Disease and Vaccine Research, Medical School, University of Massachusetts, Worcester, Massachusetts, United States of America
5 shared publicationsLei Zhang
Division of Infectious Diseases, Department of Medicine, University of Massachusetts Medical School, Worcester, USA 01655
5 shared publicationsLuz P. Acosta
Department of Immunology, Research Institute for Tropical Medicine, Manila, Philippines
5 shared publications
Latest Publications
- Open Access
- 8 July 2017
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 216 (4) , 502-503
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau
To the Editor—We read with interest the article by Do et al [1] demonstrating the effect of an early dose of measles vaccine at age 4.5 months on infant morbidity. The authors observed that infants who received the measles vaccine at 4.5 months of age had a lower hazard for diarrhea (hazard ratio [HR] = 0.89; 95% confidence interval [CI] = .82–.97), vomiting (HR = 0.86; 95% CI = .75–.98), and reported fever (HR = 0.93; 95% CI = .87–1.00) between 4.5 and 9 months of age than the infants who did not receive early measles vaccination [1]. Fever, diarrhea, and vomiting are common clinical manifestations of acute inflammatory episodes, and lower hazard ratios of these could suggest that early measles vaccination dampens subsequent general inflammatory responses. In this regard, we have observed that higher levels of opsonized attenuated measles virus (MV) stimulated higher plasmacytoid dendritic cell (pDC) transforming growth factor β (TGF-β)/interferon α (IFN-α) molar ratios compared with lower levels of opsonized attenuated MV and MV alone (Figure 1). Transforming growth factor β is an anti-inflammatory cytokine produced by pDCs [2, 3], and IFN-α is an inflammatory cytokine that is also produced by pDCs [3]. When infants are vaccinated at age 4.5 months, the circulating levels of maternally derived anti-MV immunoglobulin G (IgG) and the opsonization of attenuated MV upon measles vaccination could be more likely to promote higher anti-inflammatory/inflammatory cytokine ratios compared with when measles vaccination occurs at a later age. One potential immunological mechanism by which a heightened general anti-inflammatory response and a dampened inflammatory response could be sustained over approximately 4.5 months is MV-induced epigenetic effects on innate immune cells (trained immunity) [4]. Our data support a potential immunological mechanism by which early measles vaccination in the presence of high circulating levels of maternally derived anti-MV IgG could dampen subsequent infant inflammatory responses. This could underlie the observation by Do et al [1] that there were lower rates of fever, diarrhea, and vomiting among infants vaccinated with the measles vaccine at age 4.5 months old compared with those not vaccinated at 4.5 months of age.
- 8 July 2017
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 216 (4) , 502-503
Open AccessEffect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau
To the Editor—We read with interest the article by Do et al [1] demonstrating the effect of an early dose of measles vaccine at age 4.5 months on infant morbidity. The authors observed that infants who received the measles vaccine at 4.5 months of age had a lower hazard for diarrhea (hazard ratio [HR] = 0.89; 95% confidence interval [CI] = .82–.97), vomiting (HR = 0.86; 95% CI = .75–.98), and reported fever (HR = 0.93; 95% CI = .87–1.00) between 4.5 and 9 months of age than the infants who did not receive early measles vaccination [1]. Fever, diarrhea, and vomiting are common clinical manifestations of acute inflammatory episodes, and lower hazard ratios of these could suggest that early measles vaccination dampens subsequent general inflammatory responses. In this regard, we have observed that higher levels of opsonized attenuated measles virus (MV) stimulated higher plasmacytoid dendritic cell (pDC) transforming growth factor β (TGF-β)/interferon α (IFN-α) molar ratios compared with lower levels of opsonized attenuated MV and MV alone (Figure 1). Transforming growth factor β is an anti-inflammatory cytokine produced by pDCs [2, 3], and IFN-α is an inflammatory cytokine that is also produced by pDCs [3]. When infants are vaccinated at age 4.5 months, the circulating levels of maternally derived anti-MV immunoglobulin G (IgG) and the opsonization of attenuated MV upon measles vaccination could be more likely to promote higher anti-inflammatory/inflammatory cytokine ratios compared with when measles vaccination occurs at a later age. One potential immunological mechanism by which a heightened general anti-inflammatory response and a dampened inflammatory response could be sustained over approximately 4.5 months is MV-induced epigenetic effects on innate immune cells (trained immunity) [4]. Our data support a potential immunological mechanism by which early measles vaccination in the presence of high circulating levels of maternally derived anti-MV IgG could dampen subsequent infant inflammatory responses. This could underlie the observation by Do et al [1] that there were lower rates of fever, diarrhea, and vomiting among infants vaccinated with the measles vaccine at age 4.5 months old compared with those not vaccinated at 4.5 months of age.
- Open Access
- 29 August 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (8) , e0162148
A Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates
The Bacille Calmette Guérin (BCG) vaccine is the only routine vaccination at birth that effectively induces neonatal T-helper 1 (Th1)-polarized immune responses. The primary cytokine that drives CD4+ T-cell Th1 differentiation is interleukin (IL)-12 p70, a heterodimeric cytokine composed of the IL-12 p35 and IL-12 p40 subunits. We therefore examined the mechanisms involved in BCG vaccine stimulation of IL-12 p35 and p40 production from human umbilical cord (neonatal) cells. We found that BCG bacilli did not upregulate IL-12 p35 mRNA production, but upregulated IL-12 p40 mRNA production in a Toll-like receptor (TLR)2-dependent manner, in human neonatal monocyte-derived dendritic cells (mdDCs). The combination of TLR2 signaling, Type I interferon (IFN), and Type II IFN induced maximal levels of IL-12 p35 and p40 mRNA production in human neonatal mdDCs. The cell-free supernatants of reconstituted BCG vaccine vials contained extracellular mycobacterial (BCG) DNA which could induce IFN-α (Type I IFN) production in human neonatal plasmacytoid dendritic cells (pDCs). BCG bacilli also stimulated human neonatal CD16lo natural killer (NK) cells to produce IFN-γ (Type II IFN) in a TLR2-dependent manner. We have therefore proposed a model where BCG vaccine could stimulate the combination of neonatal conventional DCs (cDCs), pDCs, and CD16lo NK cells to produce optimal neonatal IL-12 p35 and p40 (IL-12 p70) production and subsequent CD4+ T-cell Th1 polarization. An adjuvant that emulates the mechanism by which the BCG vaccine stimulates neonatal IL-12 p35 and p40 production could improve vaccine strategies at birth for protection against intracellular pathogens and toxins.
- 29 August 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (8) , e0162148
Open AccessA Model to Explain How the Bacille Calmette Guérin (BCG) Vaccine Drives Interleukin-12 Production in Neonates
The Bacille Calmette Guérin (BCG) vaccine is the only routine vaccination at birth that effectively induces neonatal T-helper 1 (Th1)-polarized immune responses. The primary cytokine that drives CD4+ T-cell Th1 differentiation is interleukin (IL)-12 p70, a heterodimeric cytokine composed of the IL-12 p35 and IL-12 p40 subunits. We therefore examined the mechanisms involved in BCG vaccine stimulation of IL-12 p35 and p40 production from human umbilical cord (neonatal) cells. We found that BCG bacilli did not upregulate IL-12 p35 mRNA production, but upregulated IL-12 p40 mRNA production in a Toll-like receptor (TLR)2-dependent manner, in human neonatal monocyte-derived dendritic cells (mdDCs). The combination of TLR2 signaling, Type I interferon (IFN), and Type II IFN induced maximal levels of IL-12 p35 and p40 mRNA production in human neonatal mdDCs. The cell-free supernatants of reconstituted BCG vaccine vials contained extracellular mycobacterial (BCG) DNA which could induce IFN-α (Type I IFN) production in human neonatal plasmacytoid dendritic cells (pDCs). BCG bacilli also stimulated human neonatal CD16lo natural killer (NK) cells to produce IFN-γ (Type II IFN) in a TLR2-dependent manner. We have therefore proposed a model where BCG vaccine could stimulate the combination of neonatal conventional DCs (cDCs), pDCs, and CD16lo NK cells to produce optimal neonatal IL-12 p35 and p40 (IL-12 p70) production and subsequent CD4+ T-cell Th1 polarization. An adjuvant that emulates the mechanism by which the BCG vaccine stimulates neonatal IL-12 p35 and p40 production could improve vaccine strategies at birth for protection against intracellular pathogens and toxins.
- Open Access
- 4 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004267
The Pattern of Adipose Tissue Accumulation during Early Infancy Provides an Environment for the Development of Dengue Hemorrhagic Fever
Dengue is the most prevalent arthropod-borne viral illness in humans with half of the world’s population at risk. During early infancy, severe dengue can develop after a primary dengue virus infection. There has been a clinical observation that severe dengue during the first year of life is seen only in chubby infants. We examined the associations between the development of severe dengue and adipose tissue accumulation patterns during the first year of life in a prospective observational clinical study of infants and dengue virus infections. We found that adipose tissue contains two potential targets for dengue virus infection and production- adipocytes and adipose tissue macrophages. During the first year of life, total body adiposity and visceral adipose tissue stores were at their highest levels in early infancy. Early infancy was also characterized by a relative decrease in alternatively activated (anti-inflammatory) macrophages, and a relative increase in circulating pro-inflammatory cytokines. The data has been used to propose a model where the adipose tissue accumulation pattern and pro-inflammatory environment during early infancy provide the conditions for the potential development of severe dengue in immune-susceptible infants. Dengue is the most prevalent arthropod-borne viral illness in humans with half of the world’s population at risk. During early infancy, severe dengue can develop after a primary dengue virus infection. There has been a clinical observation that severe dengue during the first year of life is seen only in chubby infants. We therefore examined the associations between the development of severe dengue and adipose tissue accumulation patterns during the first year of life in a prospective observational clinical study of infants and dengue virus infections. We found that adipose tissue contains two potential targets for dengue virus infection and production- adipocytes and adipose tissue macrophages. During the first year of life, total body adiposity and visceral adipose tissue stores were at their highest levels in early infancy. Early infancy was also characterized by a relative decrease in alternatively activated (anti-inflammatory) macrophages, and a relative increase in circulating pro-inflammatory cytokines. The accumulation of visceral adipose tissue, the relative decrease in alternatively activated macrophages, and the relative increase in circulating pro-inflammatory cytokines during early infancy provide the environment for the development of severe dengue in immune-susceptible infants.
- 4 December 2015
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 9 (12) , e0004267
Open AccessThe Pattern of Adipose Tissue Accumulation during Early Infancy Provides an Environment for the Development of Dengue Hemorrhagic Fever
Dengue is the most prevalent arthropod-borne viral illness in humans with half of the world’s population at risk. During early infancy, severe dengue can develop after a primary dengue virus infection. There has been a clinical observation that severe dengue during the first year of life is seen only in chubby infants. We examined the associations between the development of severe dengue and adipose tissue accumulation patterns during the first year of life in a prospective observational clinical study of infants and dengue virus infections. We found that adipose tissue contains two potential targets for dengue virus infection and production- adipocytes and adipose tissue macrophages. During the first year of life, total body adiposity and visceral adipose tissue stores were at their highest levels in early infancy. Early infancy was also characterized by a relative decrease in alternatively activated (anti-inflammatory) macrophages, and a relative increase in circulating pro-inflammatory cytokines. The data has been used to propose a model where the adipose tissue accumulation pattern and pro-inflammatory environment during early infancy provide the conditions for the potential development of severe dengue in immune-susceptible infants. Dengue is the most prevalent arthropod-borne viral illness in humans with half of the world’s population at risk. During early infancy, severe dengue can develop after a primary dengue virus infection. There has been a clinical observation that severe dengue during the first year of life is seen only in chubby infants. We therefore examined the associations between the development of severe dengue and adipose tissue accumulation patterns during the first year of life in a prospective observational clinical study of infants and dengue virus infections. We found that adipose tissue contains two potential targets for dengue virus infection and production- adipocytes and adipose tissue macrophages. During the first year of life, total body adiposity and visceral adipose tissue stores were at their highest levels in early infancy. Early infancy was also characterized by a relative decrease in alternatively activated (anti-inflammatory) macrophages, and a relative increase in circulating pro-inflammatory cytokines. The accumulation of visceral adipose tissue, the relative decrease in alternatively activated macrophages, and the relative increase in circulating pro-inflammatory cytokines during early infancy provide the environment for the development of severe dengue in immune-susceptible infants.
- Open Access
- 30 March 2015
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 61 (4) , 310-312
Influenza virus infections in the tropics during the first year of life
Pediatric influenza virus infections in the tropics, particularly during infancy, are not well described. We identified influenza virus infections among infants with non-dengue acute undifferentiated febrile illnesses in San Pablo, Laguna, Philippines, as part of an ongoing clinical study of dengue virus infections during infancy. We found that 31% of infants with non-dengue acute undifferentiated febrile illnesses in San Pablo, Laguna, Philippines, had influenza virus infections. The majority were influenza A virus infections and outpatient cases. The infant ages were 11.1 [9.8–13.0] months (median [95% confidence interval]), and the cases clustered between June and December. Influenza episodes are a common cause of non-dengue acute undifferentiated febrile illnesses in the tropics during the first year of life.
- 30 March 2015
- Published by Oxford University Press (OUP) in Journal of Tropical Pediatrics
- Vol. 61 (4) , 310-312
Open AccessInfluenza virus infections in the tropics during the first year of life
Pediatric influenza virus infections in the tropics, particularly during infancy, are not well described. We identified influenza virus infections among infants with non-dengue acute undifferentiated febrile illnesses in San Pablo, Laguna, Philippines, as part of an ongoing clinical study of dengue virus infections during infancy. We found that 31% of infants with non-dengue acute undifferentiated febrile illnesses in San Pablo, Laguna, Philippines, had influenza virus infections. The majority were influenza A virus infections and outpatient cases. The infant ages were 11.1 [9.8–13.0] months (median [95% confidence interval]), and the cases clustered between June and December. Influenza episodes are a common cause of non-dengue acute undifferentiated febrile illnesses in the tropics during the first year of life.
- Open Access
- 1 February 2015
- Published by Elsevier in Acta Tropica
- Vol. 142, 103-107
Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections
- 1 February 2015
- Published by Elsevier in Acta Tropica
- Vol. 142, 103-107
Open AccessAnti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections
- Open Access
- 28 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e98509
Circulating Levels of Soluble MICB in Infants with Symptomatic Primary Dengue Virus Infections
Dengue is the most prevalent arthropod-borne viral illness in humans. A MHC class I polypeptide-related sequence B (MICB) single nucleotide polymorphism (SNP) was previously associated with symptomatic dengue compared to non-dengue causes of acute febrile illnesses in infants. We measured circulating levels of soluble (s)MICB in the sera of infants with symptomatic primary dengue virus infections. We found that serum levels of sMICB increased between pre-infection and acute illness among infants with symptomatic primary dengue virus infections. The likelihood of being hospitalized with an acute primary DENV infection during infancy also tended to be higher with increasing acute illness sMICB levels. The elevation of sMICB during acute primary DENV infections in infants likely represents an immune evasion strategy and contributes to the severity of the acute illness.
- 28 May 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (5) , e98509
Open AccessCirculating Levels of Soluble MICB in Infants with Symptomatic Primary Dengue Virus Infections
Dengue is the most prevalent arthropod-borne viral illness in humans. A MHC class I polypeptide-related sequence B (MICB) single nucleotide polymorphism (SNP) was previously associated with symptomatic dengue compared to non-dengue causes of acute febrile illnesses in infants. We measured circulating levels of soluble (s)MICB in the sera of infants with symptomatic primary dengue virus infections. We found that serum levels of sMICB increased between pre-infection and acute illness among infants with symptomatic primary dengue virus infections. The likelihood of being hospitalized with an acute primary DENV infection during infancy also tended to be higher with increasing acute illness sMICB levels. The elevation of sMICB during acute primary DENV infections in infants likely represents an immune evasion strategy and contributes to the severity of the acute illness.
- Open Access
- 12 February 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e88944
Low Adiposity during Early Infancy Is Associated with a Low Risk for Developing Dengue Hemorrhagic Fever: A Preliminary Model
Dengue virus (DENV) infections range from asymptomatic or mild illness to a severe and potentially life threatening disease, dengue hemorrhagic fever (DHF). DHF occurs in primary DENV infections during early infancy. A prospective clinical study of DENV infections during infancy was conducted in San Pablo, Philippines. We found that infants who developed DHF with a primary DENV infection had higher WHO weight-for-age z scores before and at the time of infection compared to infants with primary DENV infections who did not develop DHF. In addition, TLR 7/8-stimulated tumor necrosis factor-α (TNF-α) production from myeloid-derived cells was higher among well-nourished infants. Leptin augmented TLR 7/8-mediated TNF-α production in monocytes and decreased intracellular cAMP levels. Circulating leptin levels were elevated during early infancy and correlated with WHO weight-for-age z scores. Our data support a plausible hypothesis as to why well-nourished infants are at risk for developing DHF with their first DENV infection.
- 12 February 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e88944
Open AccessLow Adiposity during Early Infancy Is Associated with a Low Risk for Developing Dengue Hemorrhagic Fever: A Preliminary Model
Dengue virus (DENV) infections range from asymptomatic or mild illness to a severe and potentially life threatening disease, dengue hemorrhagic fever (DHF). DHF occurs in primary DENV infections during early infancy. A prospective clinical study of DENV infections during infancy was conducted in San Pablo, Philippines. We found that infants who developed DHF with a primary DENV infection had higher WHO weight-for-age z scores before and at the time of infection compared to infants with primary DENV infections who did not develop DHF. In addition, TLR 7/8-stimulated tumor necrosis factor-α (TNF-α) production from myeloid-derived cells was higher among well-nourished infants. Leptin augmented TLR 7/8-mediated TNF-α production in monocytes and decreased intracellular cAMP levels. Circulating leptin levels were elevated during early infancy and correlated with WHO weight-for-age z scores. Our data support a plausible hypothesis as to why well-nourished infants are at risk for developing DHF with their first DENV infection.
- Open Access
- 1 January 2014
- Published by Elsevier in Trials in Vaccinology
- Vol. 3, 1-5
Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines
- 1 January 2014
- Published by Elsevier in Trials in Vaccinology
- Vol. 3, 1-5
Open AccessNeonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines
- Open Access
- 25 October 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e78018
Toll-Like Receptor Induced Pro-Interleukin-1β and Interleukin-6 in Monocytes Are Lower in Healthy Infants Compared to Adults
Infants have long been known to have higher infectious diseases morbidity and mortality and suboptimal vaccination responses compared to older children and adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. We compared Toll-like receptor (TLR)-induced production of pro-interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α between 2-month-old infants and adults. TLR 7/8-induced production of pro-IL-1β and IL-6 in monocytes was lower in 2-month-old infants compared to adults. There was no difference in TLR 7/8-induced production of TNF-α. Lower TLR-induced production of pro-IL-1β and IL-6 in innate immune cells during early infancy likely contributes to suboptimal vaccine responses and infectious diseases susceptibility.
- 25 October 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e78018
Open AccessToll-Like Receptor Induced Pro-Interleukin-1β and Interleukin-6 in Monocytes Are Lower in Healthy Infants Compared to Adults
Infants have long been known to have higher infectious diseases morbidity and mortality and suboptimal vaccination responses compared to older children and adults. A variety of differences in innate and adaptive immune responses have been described between these two groups. We compared Toll-like receptor (TLR)-induced production of pro-interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α between 2-month-old infants and adults. TLR 7/8-induced production of pro-IL-1β and IL-6 in monocytes was lower in 2-month-old infants compared to adults. There was no difference in TLR 7/8-induced production of TNF-α. Lower TLR-induced production of pro-IL-1β and IL-6 in innate immune cells during early infancy likely contributes to suboptimal vaccine responses and infectious diseases susceptibility.